Application | Comment | Organism |
---|---|---|
medicine | oral dipeptidyl peptidase-4 inhibitors may prove valuable in the treatment of diabetes, given their effectiveness in reducing glycated hemoglobin with neutral weight effects and without the adverse events associated with other agents. Dipeptidyl peptidase-4 inhibitors appear to improve islet function and may modify the course of diabetes | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
sitagliptin | - |
Homo sapiens | |
vildagliptin | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
dipeptidyl peptidase-4 | - |
Homo sapiens |
DPP-4 | - |
Homo sapiens |